Haptic patch narrows leg strength gap in NCAA athletes

A drug-free haptic patch improved non-dominant leg strength and jump symmetry in a randomized placebo-controlled trial of 70 NCAA Division I athletes presented in Angers, France. The finding could matter for return-to-play and injury-prevention programs if larger studies confirm the effect.

Why it matters: - Large strength differences between an athlete's two legs are a common screening marker in return-to-play and injury-prevention programs. - The trial suggests a non-drug option may help reduce that asymmetry. - If confirmed in larger studies, the patch could become a practical tool for coaches, trainers and sports medicine staff.

What happened: - Researchers presented results from the POWER-UP randomized trial at the 14th International Congress on Sport Sciences Research and Technology Support (icSPORTS 2026) in Angers, France. - The study tested a drug-free haptic vibrotactile transduction patch on NCAA Division I athletes. - The patch was applied to the dominant thigh. - Peter Hurwitz, president of Clarity Science, LLC, presented the findings with co-authors Jason Taporco, MD, and Mark Sakr, DO, of the University of Arizona College of Medicine.

The details: - The trial included 70 athletes, including 40 women and 30 men. - Each athlete wore both the active patch and a visually identical placebo patch in random order. - The study was blinded. - Researchers used a 7- to 10-day washout period between conditions. - Average wear time before testing was about 3.8 hours. - Strength was measured with isokinetic knee dynamometry. - Jump force was measured with a force plate. - The non-dominant leg strength of athletes came up to parity with the dominant leg strength after use of the active patch. - Left knee-flexion peak force rose 7% with the active patch versus 2% with placebo. - The gain was significantly greater than placebo for maximum force, with p=0.005. - The gain was also significantly greater than placebo for average force, with p=0.009.

Between the lines: - The result is a placebo-controlled signal, not proof the patch reduces injuries or improves performance over time. - Hurwitz said the finding is worth testing in larger studies that track actual injuries and recovery. - The technology is intended to stimulate touch receptors in the skin. - The proposed signal may involve PIEZO1 and PIEZO2 ion channels and then travel toward the brain's motor-control centers. - That mechanism remains a plausible explanation rather than a proven one.

What's next: - Larger studies will need to test whether the strength changes hold up in broader athlete populations. - Future research also needs to show whether the patch affects injury rates and recovery. - The full product information is available at more information.

The bottom line: - The patch showed a measurable, placebo-adjusted improvement in leg strength symmetry in elite college athletes, but its real-world sports value still needs confirmation.